Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. | J Cancer | 2021 | 34093804 | PubTator, text mining | PubMed |
| Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era. | BMC Med Genomics | 2021 | 34092239 | PubTator, text mining | PubMed |
| Searching for new molecular markers for cells obtained from abdominal aortic aneurysm. | J Appl Genet | 2021 | 34080122 | PubTator, text mining | PubMed |
| Molecular Profiles of Brain Metastases: A Focus on Heterogeneity. | Cancers (Basel) | 2021 | 34071176 | PubTator, text mining | PubMed |
| Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 34070940 | PubTator, text mining | PubMed |
| Emerging Roles of SKP2 in Cancer Drug Resistance. | Cells | 2021 | 34068643 | PubTator, text mining | PubMed |
| Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape. | Int J Mol Sci | 2021 | 34067929 | PubTator, text mining | PubMed |
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. | Cancers (Basel) | 2021 | 34067823 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness. | Int J Mol Sci | 2021 | 34065317 | PubTator, text mining | PubMed |
| Collagen in Wound Healing. | Bioengineering (Basel) | 2021 | 34064689 | PubTator, text mining | PubMed |
| Understanding the Adult Mammalian Heart at Single-Cell RNA-Seq Resolution. | Front Cell Dev Biol | 2021 | 34055776 | PubTator, text mining | PubMed |
| Next-generation sequencing revealed synchronous double primary lung squamous carcinoma: a case report. | J Int Med Res | 2021 | 34038210 | PubTator, text mining | PubMed |
| The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium. | Clin Epigenetics | 2021 | 34034824 | PubTator, text mining | PubMed |
| A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer. | Technol Cancer Res Treat | 2021 | 34032165 | PubTator, text mining | PubMed |
| Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. | Cell Commun Signal | 2021 | 34022881 | PubTator, text mining | PubMed |
| Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer. | Genome Med | 2021 | 34016182 | PubTator, text mining | PubMed |
| Utilizing graph machine learning within drug discovery and development. | Brief Bioinform | 2021 | 34013350 | PubTator, text mining | PubMed |
| Identification of genetic variations associated with drug resistance in non-small cell lung cancer patients undergoing systemic treatment. | Brief Bioinform | 2021 | 34013324 | PubTator, text mining | PubMed |
| Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers. | Sci Rep | 2021 | 34006948 | PubTator, text mining | PubMed |
| Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. | Front Oncol | 2021 | 33996610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=47